Abstract Gamma-aminobutyric type A receptor (GABAAR) is a member of the Cys-loop family of pentameric ligand gated ion channels (pLGICs). It has been identified as a key target for many clinical drugs. In the present study, we construct the structure of human 2α12β2γ2 GABAAR using a homology modeling method. The structures of ten benzodiazepine type drugs and two non-benzodiazepine type drugs were then docked into the potential benzodiazepine binding site on the GABAAR. By analyzing the docking results, the critical residues His102 (α1), Phe77 (γ2) and Phe100 (α1) were identified in the binding site. To gain insight into the binding affinity, molecular dynamics (MD) simulations were performed for all the receptor–ligand complexes. We also examined single mutant GABAAR (His102A) in complexes with the three drugs (flurazepam, eszopiclone and zolpidem) to elucidate receptor–ligand interactions. For each receptor–ligand complex (with flurazepam, eszopiclone and zolpidem), we calculated the average distance between the Cα of the mutant residue His102A (α1) to the center of mass of the ligands. The results reveal that the distance between the Cα of the mutant residue His102A (α1) to the center of flurazepam is larger than that between His102 (α1) to flurazepam in the WT type complex. Molecular mechanic-generalized Born surface area (MM-GBSA)-based binding free energy calculations were performed. The binding free energy was decomposed into ligand-residue pairs to create a ligand-residue interaction spectrum. The predicted binding free energies correlated well (R 2 = 0.87) with the experimental binding free energies. Overall, the major interaction comes from a few groups around His102 (α1), Phe77 (γ2) and Phe100 (α1). These groups of interaction consist of at least of 12 residues in total with a binding energy of more than 1 kcal mol−1. The simulation study disclosed herein provides a meaningful insight into GABAAR–ligand interactions and helps to arrive at a binding mode hypothesis with implications for drug design.
α1                  0.99999987258503^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Gamma-aminobutyric_acid_receptor_subunit_alpha-1

ligands                       0.999956478687932^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Ligand_(biochemistry) 

kcal                          0.9999999999213287^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Calorie               

mass                          0.8121041323606901^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mass                  

eszopiclone                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Eszopiclone           

mutant                        0.9995054701994124^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

surface area                  0.9999896423969205^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Surface_area          

binding site                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Binding_site          

zolpidem                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Zolpidem              

single                        0.9999906152481065^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Single_bond           

flurazepam                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Flurazepam            

binding site                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Binding_site          

residues                      0.9999796361409876^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Amino_acid            

residues                      0.9999796361409876^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Amino_acid            

pentameric                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pentamer              

eszopiclone                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Eszopiclone           

molecular dynamics            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_dynamics    

non-benzodiazepine            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nonbenzodiazepine     

α1                            0.99999987258503^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Gamma-aminobutyric_acid_receptor_subunit_alpha-1

binding energy                0.7494740112022253^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Binding_energy        

drugs                         0.9999999132167015^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

zolpidem                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Zolpidem              

MD                            0.5514345462844372^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Doctor_of_Medicine    

drugs                         0.9999999132167015^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

flurazepam                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Flurazepam            

free energy calculations      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gibbs_free_energy     

free energies                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Thermodynamic_free_energy

benzodiazepine                0.8514165020429718^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/GABAA_receptor        

flurazepam                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Flurazepam            

simulation                    0.9868051455841813^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Computer_simulation   

WT                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Wild_type             

binding affinity              0.9999995441772755^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ligand_(biochemistry) 

α1                            0.99999987258503^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Gamma-aminobutyric_acid_receptor_subunit_alpha-1

mutant                        0.9995054701994124^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

flurazepam                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Flurazepam            

mutant                        0.9995054701994124^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

receptor                      0.9999999999984084^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Receptor_(biochemistry)

drugs                         0.9999999132167015^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

ligand gated ion channels     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ligand-gated_ion_channel

family                        0.9999999999699867^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein_family        

α1                            0.99999987258503^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Gamma-aminobutyric_acid_receptor_subunit_alpha-1

free energy                   0.9999999996991846^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Thermodynamic_free_energy

α1                            0.99999987258503^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Gamma-aminobutyric_acid_receptor_subunit_alpha-1

α1                            0.99999987258503^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Gamma-aminobutyric_acid_receptor_subunit_alpha-1

homology modeling             0.9937855835970226^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein_structure_prediction

free energies                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Thermodynamic_free_energy

α1                            0.99999987258503^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Gamma-aminobutyric_acid_receptor_subunit_alpha-1

drugs                         0.9999999132167015^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

drug design                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Drug_design           

benzodiazepine                0.8514165020429718^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/GABAA_receptor        

Cys-loop                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cys-loop_receptors    

hypothesis                    0.9999977735637686^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hypothesis            

